Scynexis (SCYX) Income towards Parent Company (2013 - 2026)

Scynexis (SCYX) posted Income towards Parent Company of -$16.4 million for Q1 2026, down 234.03% on a QoQ basis from $12.3 million in Q4 2025, and down 204.75% year-over-year from $15.7 million in Q1 2025.

Scynexis (SCYX) Income towards Parent Company (2013 - 2026) Analysis & Trends

Scynexis' Income towards Parent Company history runs 13 years deep, the most recent figure standing at -$16.4 million for Q1 2026.

  • Quarterly Income towards Parent Company fell 204.75% year-over-year to -$16.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$19.6 million (up 27.61% YoY) and the FY2025 annual result came in at -$8.6 million, up 59.65% from the prior year.
  • Income towards Parent Company was -$16.4 million for Q1 2026 at Scynexis, down from $12.3 million in the prior quarter.
  • Across five years, Income towards Parent Company topped out at $122.3 million in Q2 2023 and bottomed at -$33.9 million in Q1 2023.
  • A 5-year average of -$2.9 million and a median of -$6.9 million in 2025 frame the typical range for Income towards Parent Company.
  • Annual changes were most pronounced in 2022 — Income towards Parent Company plunged 4789.92% — and 2023, when it soared 1016.15%.
  • Scynexis' Income towards Parent Company stood at -$19.5 million in 2022, then dropped by 9.06% to -$21.3 million in 2023, then surged by 78.92% to -$4.5 million in 2024, then surged by 373.49% to $12.3 million in 2025, then plunged by 234.03% to -$16.4 million in 2026.
  • Business Quant data shows SCYX's Income towards Parent Company at -$16.4 million in Q1 2026, $12.3 million in Q4 2025, and -$8.6 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 89.28 Bn 87.42 Bn -
2 Teva Pharmaceutical Industries 35.97 Bn 32.23 Bn 1.97 Bn
3 Zoetis 32.42 Bn 30.48 Bn 1.62 Bn
4 Takeda Pharmaceutical 27.48 Bn 23.42 Bn 4.39 Bn
5 United Therapeutics 22.89 Bn 20.73 Bn 648.10 Mn
6 RedHill Biopharma 22.11 Bn 22.11 Bn -
7 Viatris 20.44 Bn 18.64 Bn 1.16 Bn
8 Neurocrine Biosciences 17.76 Bn 16.44 Bn 800.70 Mn
9 Elanco Animal Health 12.62 Bn 12.19 Bn 785.00 Mn
10 Scynexis 23.19 Mn -13.57 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 -16.43 Mn
Dec 31, 2025 12.26 Mn
Sep 30, 2025 -8.59 Mn
Jun 30, 2025 -6.89 Mn
Mar 31, 2025 -5.39 Mn
Dec 31, 2024 -4.48 Mn
Sep 30, 2024 -2.81 Mn
Jun 30, 2024 -14.46 Mn
Mar 31, 2024 411,000.00
Dec 31, 2023 -21.27 Mn
Sep 30, 2023 -1.76 Mn
Jun 30, 2023 122.26 Mn
Mar 31, 2023 -33.88 Mn
Dec 31, 2022 -19.50 Mn
Sep 30, 2022 -29.58 Mn
Jun 30, 2022 -13.35 Mn
Mar 31, 2022 -5.45 Mn
Dec 31, 2021 -29.28 Mn
Sep 30, 2021 -605,000.00
Jun 30, 2021 1.66 Mn